65 employees
TAE Life Sciences is an pre-clinical biotechnology company developing comprehensive biologically-targeted radiation therapy
2017
$40M
from 2 investors over 2 rounds
TAE Life Sciences raised $30M on June 2, 2020
Investors: ARTIS Ventures
TAE Life Sciences raised $40M on March 13, 2018